{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:48:28Z","timestamp":1784580508943,"version":"3.55.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"\n Importance<\/jats:title>\n Fluorescence-guided surgery aims to improve intraoperative identification of vital structures. Rizedisben is a myelin-binding fluorophore that fluoresces in the blue light (370-425 nm) spectrum to improve intraoperative nerve identification.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine the optimal safe and clinically effective dose of rizedisben for sustained intraoperative fluorescence of nerve structures.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A single-arm, open-label, phase 1 study was conducted in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP) at an urban academic cancer center in New York City between January 2023 and October 2024. Using a dose escalation design, increasing doses of rizedisben were administered after safety was assessed at each level until a clinically effective dose was determined. The obturator nerve served as the reference nerve for measuring fluorescence intensity. Eligible patients were 18 years old and older, diagnosed with prostate cancer, and scheduled for RALP. Patients were recruited in preoperative clinic visits once deemed eligible for the study. Those with prior pelvic surgery or radiation, known central or peripheral nervous system disease, current use of neurotoxic medications, recent exposure to phototoxic drugs, or serious kidney or liver dysfunction were excluded.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Rizedisben was intravenously administered intraoperatively 30 minutes prior to visualization of the obturator nerve.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Safety was assessed through 45 postoperative days. Fluorescence was measured via subjective intraoperative scoring and by post hoc objective image analysis. Clinically effective dose was defined as achieving sustained fluorescence of the obturator nerve in 3 or more of 5 patients in 2 consecutive cohorts, provided fewer than 20% of patients experienced grade 2 or greater toxicity. Sustained fluorescence was defined as moderate or better fluorescence for 90 minutes or longer. At the clinically effective dose, fluorescence assessments of the neurovascular bundles were included.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Thirty-eight patients (median [IQR] age, 61.5 [57.8-66.3] years) enrolled in and completed the trial. Dosing was escalated from 0.25 to 3.0 mg\/kg. There was 1 grade 2 adverse event (rash) possibly attributable to rizedisben. Sustained fluorescence of the obturator nerve was achieved in all patients at 3.0 mg\/kg. Prostate neurovascular bundles demonstrated evidence of fluorescence in 8 of 9 (89%) patients at 3.0 mg\/kg.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this phase 1 trial of rizedisben, the 3.0-mg\/kg dose was shown to be generally well tolerated and clinically effective. At this dose, there was excellent sustained fluorescence of the obturator nerves, and the neurovascular bundles were visualized in 8 of 9 patients. Based on these data, we are designing phase 2 studies with rizedisben for additional indications.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT04983862<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamasurg.2025.1987","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:00:25Z","timestamp":1751454025000},"page":"875","source":"Crossref","is-referenced-by-count":6,"title":["Rizedisben in Minimally Invasive Surgery"],"prefix":"10.1001","volume":"160","author":[{"given":"Samuel A.","family":"Gold","sequence":"first","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Pere","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Assel","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Doudt","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Urology, Naval Medical Center Portsmouth, Portsmouth, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trey D.","family":"Durdin","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Urology Service, Department of Surgery, Hendrick Medical Center, Abilene, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Silagy","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Urology Department, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas W.","family":"Dean","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Surgery Department, University of Alberta, Edmonton, Alberta, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Recabal","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Instituto Oncol\u00f3gico, Fundaci\u00f3n Arturo Lopez Perez, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Levine","sequence":"additional","affiliation":[{"name":"Office of Technology Development, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Burke","sequence":"additional","affiliation":[{"name":"Office of Technology Development, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Ragupathi","sequence":"additional","affiliation":[{"name":"Clinical Grade Production Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R.","family":"Marzabadi","sequence":"additional","affiliation":[{"name":"Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Ke","family":"Yao","sequence":"additional","affiliation":[{"name":"Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbin","family":"Yang","sequence":"additional","affiliation":[{"name":"Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangli","family":"Yang","sequence":"additional","affiliation":[{"name":"Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouathek","family":"Ouerfelli","sequence":"additional","affiliation":[{"name":"Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"McCarter","sequence":"additional","affiliation":[{"name":"Research and Technology Management, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathia","family":"Tzatha","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital for Special Surgery, Department, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Coleman","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin C.","family":"Goh","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behfar","family":"Ehdaie","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Vickers","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Scardino","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Eastham","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent P.","family":"Laudone","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy F.","family":"Donahue","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9522","key":"soi250033r1","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(06)68700-X","article-title":"Persistent postsurgical pain: risk factors and prevention.","volume":"367","author":"Kehlet","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"soi250033r2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ca.23696","article-title":"The most commonly injured nerves at surgery: a comprehensive review.","volume":"34","author":"Sharp","year":"2021","journal-title":"Clin Anat"},{"issue":"5","key":"soi250033r3","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.juro.2017.12.037","article-title":"The effect of nerve sparing status on sexual and urinary function: 3-year results from the CEASAR Study.","volume":"199","author":"Avulova","year":"2018","journal-title":"J Urol"},{"issue":"4","key":"soi250033r4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.juro.2017.02.3344","article-title":"The risks and benefits of cavernous neurovascular bundle sparing during radical prostatectomy: a systematic review and meta-analysis.","volume":"198","author":"Nguyen","year":"2017","journal-title":"J Urol"},{"issue":"1","key":"soi250033r5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0003489416675354","article-title":"Intraoperative neurophysiological monitoring of the laryngeal nerves during anterior neck surgery: a review.","volume":"126","author":"Tewari","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"2","key":"soi250033r6","doi-asserted-by":"publisher","first-page":"E85","DOI":"10.1093\/ons\/opaa329","article-title":"Robotic resection of a nerve sheath tumor via a retroperitoneal approach.","volume":"20","author":"Rapoport","year":"2021","journal-title":"Oper Neurosurg (Hagerstown)"},{"issue":"4","key":"soi250033r7","doi-asserted-by":"publisher","DOI":"10.1088\/2050-6120\/ac1dbb","article-title":"Fluorescence guided surgery.","volume":"9","author":"Stewart","year":"2021","journal-title":"Methods Appl Fluoresc"},{"key":"soi250033r8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fonc.2017.00314","article-title":"Fluorescence-guided surgery.","volume":"7","author":"Nagaya","year":"2017","journal-title":"Front Oncol"},{"issue":"11","key":"soi250033r9","doi-asserted-by":"publisher","first-page":"6227","DOI":"10.1007\/s00464-024-11236-5","article-title":"State of the art medical devices for fluorescence-guided surgery (FGS): technical review and future developments.","volume":"38","author":"Preziosi","year":"2024","journal-title":"Surg Endosc"},{"issue":"1","key":"soi250033r10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41698-024-00699-3","article-title":"Illuminating the future of precision cancer surgery with fluorescence imaging and artificial intelligence convergence.","volume":"8","author":"Cheng","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"soi250033r11","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.30.S1.S13707","article-title":"Two-color fluorescence-guided surgery for head and neck cancer resections.","volume":"30","author":"Szafran","year":"2025","journal-title":"J Biomed Opt"},{"issue":"6","key":"soi250033r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2016.01.008","article-title":"The effect of minimally invasive prostatectomy on practice patterns of American urologists.","volume":"34","author":"Oberlin","year":"2016","journal-title":"Urol Oncol"},{"issue":"2","key":"soi250033r13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.eururo.2016.01.026","article-title":"A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimisation of cancer control and preservation of continence and erection in candidates for radical prostatectomy: an update.","volume":"70","author":"Walz","year":"2016","journal-title":"Eur Urol"},{"issue":"5","key":"soi250033r14","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.21037\/tau.2020.03.17","article-title":"A review of technical progression in the robot-assisted radical prostatectomy.","volume":"10","author":"Cho","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"6","key":"soi250033r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130276","article-title":"Improved intraoperative visualization of nerves through a myelin-binding fluorophore and dual-mode laparoscopic imaging.","volume":"10","author":"Cotero","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"soi250033r16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis.","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"6","key":"soi250033r17","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1212\/WNL.45.6.1115","article-title":"Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects.","volume":"45","author":"Dyck","year":"1995","journal-title":"Neurology"},{"issue":"6","key":"soi250033r18","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00520-015-3032-y","article-title":"Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.","volume":"24","author":"Beijers","year":"2016","journal-title":"Support Care Cancer"},{"issue":"2","key":"soi250033r19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"soi250033r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v015.i02","article-title":"The R Package geepack for generalized estimating equations.","volume":"15","author":"Halekoh","year":"2006","journal-title":"J Stat Softw"},{"issue":"4","key":"soi250033r21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ejvs.2011.12.030","article-title":"Indocyanine green angiography for intra-operative assessment in vascular surgery.","volume":"43","author":"Yamamoto","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"10","key":"soi250033r22","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s00268-010-0676-0","article-title":"Fluorescent cholangiography during laparoscopic cholecystectomy: indocyanine green or new fluorescent agents?","volume":"34","author":"Ishizawa","year":"2010","journal-title":"World J Surg"},{"issue":"4","key":"soi250033r23","doi-asserted-by":"publisher","first-page":"1003e","DOI":"10.1097\/PRS.0000000000003218","article-title":"Current concepts in the surgical management of lymphedema.","volume":"139","author":"Kung","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"soi250033r24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5173\/ceju.2014.02.art5","article-title":"Usage of invisible near infrared light (NIR) fluorescence with indocyanine green (ICG) and methylene blue (MB) in urological oncology. Part 1.","volume":"67","author":"Polom","year":"2014","journal-title":"Cent European J Urol"},{"issue":"1","key":"soi250033r25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/01.ju.0000060782.52358.04","article-title":"Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer\u2014a multicenter study.","volume":"170","author":"Jichlinski","year":"2003","journal-title":"J Urol"},{"key":"soi250033r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2023.102361","article-title":"Improving precision surgery: a review of current intraoperative nerve tissue fluorescence imaging.","volume":"76","author":"Wang","year":"2023","journal-title":"Curr Opin Chem Biol"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2835766\/jamasurgery_gold_2025_oi_250033_1763151467.24299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T16:00:36Z","timestamp":1763568036000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2835766"}},"subtitle":["A Nonrandomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2025.1987","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}